It's closed its labs and fired much of the staff, so it seems likely it'll go bankrupt, but I don't think they have yet.
But I guess from the perspective of an investor, you can either wait and try to spend money hiring lawyers to sue a broke company for a judgement they won't be able to pay you anyways, or you can take more shares in the .001% chance that they'll somehow rise from the ashes and you'll get some non-zero payout.
10 comments
[ 5.5 ms ] story [ 32.1 ms ] threadBut I guess from the perspective of an investor, you can either wait and try to spend money hiring lawyers to sue a broke company for a judgement they won't be able to pay you anyways, or you can take more shares in the .001% chance that they'll somehow rise from the ashes and you'll get some non-zero payout.
You can run a company for quite a while on $110M, even in Silicon Valley.
https://www.glassdoor.com/Reviews/Theranos-Reviews-E248889.h...
The PR department must work overtime to scrub any negative reviews.
Brilliant